Last reviewed · How we verify

NCT07503964: DILAILA

The Significance of Laparoscopic Transcystic Papilla Vateri Balloon Dilatation in Patients With Choledocholithiasis.

Active, enrolled NA Last updated 31 March 2026
What this trial tests

NA trial testing Endoscopic retrograde cholangiopancreatography with papillotomy and stone evacuation from common bile duct. in Choledocholithiasis in 100 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 May 2025
Primary endpoint
1 October 2027
1 October 2028

Quick facts

Lead sponsorRiga East Clinical University Hospital
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 May 2025
Primary completion1 October 2027
Estimated completion1 October 2028
Sites1 location across Latvia

Drugs / interventions tested

Conditions studied

Sponsor

Riga East Clinical University Hospital

Who can join

18 and older, any sex, with Choledocholithiasis or Choledocholithiasis With Cholecystitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective randomized trial. It is planned to analyze groups of patients with cholecystitis and choledocholithiasis. As part of the study, after signing the consent, the patients will be divided into two groups that have indications for surgical therapy. A two-stage therapy will be applied to one group, where initially endoscopic retrograde cholangiopancreatography with evacuation of gallstone from the common bile duct will be prescribed, and as the second stage, patients will undergo surgery - laparoscopic cholecystectomy. For the second group, a one-stage therapy tactic will be applied, where during the operation (laparoscopic cholecystectomy), transcystic papilla Vateri balloon dilation with antegrade gallstone evacuation from the common bile duct will be applied. For patients who will be proven to have a stone in the common bile duct and patients who meet the study inclusion criteria, a sealed envelope will be placed in the medical history with a specific therapeutic tactic that will be applied to the patient's treatment. Each envelope will be assigned a number. Using a computer and a randomizer, an envelope with a number will be selected, which will be assigned to each patient. The postoperative course, duration of surgery, length of hospitalization, types of complications and their frequency after surgery, the creator of successful outcomes, the cost of the treatment method in the specific medical institution will be analyzed. The data will be processed with the IBM SPSS program and analyzed according to the parametric/non-parametric distribution of the data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Choledocholithiasis

Currently open trials in the same condition.

Other Riga East Clinical University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07503964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing